These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21508934)

  • 1. Reduced cortical thickness is associated with the glutamatergic regulatory gene risk variant DAOA Arg30Lys in schizophrenia.
    Schultz CC; Nenadic I; Koch K; Wagner G; Roebel M; Schachtzabel C; Mühleisen TW; Nöthen MM; Cichon S; Deufel T; Kiehntopf M; Rietschel M; Reichenbach JR; Sauer H; Schlösser RG
    Neuropsychopharmacology; 2011 Jul; 36(8):1747-53. PubMed ID: 21508934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in the DAOA (G72) gene modulates hippocampal function in subjects at high risk of schizophrenia.
    Hall J; Whalley HC; Moorhead TW; Baig BJ; McIntosh AM; Job DE; Owens DG; Lawrie SM; Johnstone EC
    Biol Psychiatry; 2008 Sep; 64(5):428-33. PubMed ID: 18423426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined study of genetic association and brain imaging on the DAOA gene in schizophrenia.
    Chen J; Xu Y; Zhang J; Liu Z; Xu C; Zhang K; Shen Y; Xu Q
    Am J Med Genet B Neuropsychiatr Genet; 2013 Mar; 162B(2):191-200. PubMed ID: 23335491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic association of the DAOA gene with resting-state brain activity in major depression.
    Chen J; Xu Y; Zhang J; Liu Z; Xu C; Zhang K; Shen Y; Xu Q
    Mol Neurobiol; 2012 Oct; 46(2):361-73. PubMed ID: 22851402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DTNBP1 is associated with imaging phenotypes in schizophrenia.
    Narr KL; Szeszko PR; Lencz T; Woods RP; Hamilton LS; Phillips O; Robinson D; Burdick KE; DeRosse P; Kucherlapati R; Thompson PM; Toga AW; Malhotra AK; Bilder RM
    Hum Brain Mapp; 2009 Nov; 30(11):3783-94. PubMed ID: 19449336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical thickness and surface area in neonates at high risk for schizophrenia.
    Li G; Wang L; Shi F; Lyall AE; Ahn M; Peng Z; Zhu H; Lin W; Gilmore JH; Shen D
    Brain Struct Funct; 2016 Jan; 221(1):447-61. PubMed ID: 25362539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sample.
    Corvin A; McGhee KA; Murphy K; Donohoe G; Nangle JM; Schwaiger S; Kenny N; Clarke S; Meagher D; Quinn J; Scully P; Baldwin P; Browne D; Walsh C; Waddington JL; Morris DW; Gill M
    Am J Med Genet B Neuropsychiatr Genet; 2007 Oct; 144B(7):949-53. PubMed ID: 17492767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of TMX2-CTNND1 polymorphism on cortical thickness in schizophrenia patients and unaffected siblings: an exploratory study based on target region sequencing.
    Tan W; Cheng Y; Huang D; Liu D; Zhang J; Li J; Liu Z; Pan Y
    Braz J Psychiatry; 2024; 46():e20233322. PubMed ID: 38219215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DAOA gene is associated with schizophrenia in the Taiwanese population.
    Chu CS; Chow PC; Cohen-Woods S; Gaysina D; Tang KY; McGuffin P
    Psychiatry Res; 2017 Jun; 252():201-207. PubMed ID: 28285246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical surface area correlates with STON2 gene Ser307Pro polymorphism in first-episode treatment-naïve patients with schizophrenia.
    Xiang B; Wu JY; Wang Q; Li ML; Jiang LJ; Deng W; Chen ZF; He ZL; Huang CH; Han YY; Li YF; Lin Y; Liu X; Wang YC; Ma XH; Gong QY; Li T; Hu X
    PLoS One; 2013; 8(6):e64090. PubMed ID: 23785397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common variation in NCAN, a risk factor for bipolar disorder and schizophrenia, influences local cortical folding in schizophrenia.
    Schultz CC; Mühleisen TW; Nenadic I; Koch K; Wagner G; Schachtzabel C; Siedek F; Nöthen MM; Rietschel M; Deufel T; Kiehntopf M; Cichon S; Reichenbach JR; Sauer H; Schlösser RG
    Psychol Med; 2014 Mar; 44(4):811-20. PubMed ID: 23795679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DAOA ARG30LYS and verbal memory function in schizophrenia.
    Donohoe G; Morris DW; Robertson IH; McGhee KA; Murphy K; Kenny N; Clarke S; Gill M; Corvin AP
    Mol Psychiatry; 2007 Sep; 12(9):795-6. PubMed ID: 17767147
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic variation in the DAOA gene complex: impact on susceptibility for schizophrenia and on cognitive performance.
    Opgen-Rhein C; Lencz T; Burdick KE; Neuhaus AH; DeRosse P; Goldberg TE; Malhotra AK
    Schizophr Res; 2008 Aug; 103(1-3):169-77. PubMed ID: 18541412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic meta-analysis of the association of Neuregulin 1 (NRG1), D-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia.
    Jagannath V; Gerstenberg M; Correll CU; Walitza S; Grünblatt E
    J Neural Transm (Vienna); 2018 Jan; 125(1):89-102. PubMed ID: 28864885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of NOS1AP, DISC1, DAOA, and GSK3B confers susceptibility of early-onset schizophrenia in Chinese Han population.
    Hu G; Yang C; Zhao L; Fan Y; Lv Q; Zhao J; Zhu M; Guo X; Bao C; Xu A; Jie Y; Jiang Y; Zhang C; Yu S; Wang Z; Li Z; Yi Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():187-193. PubMed ID: 29100974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association analyses of the DAOA/G30 and D-amino-acid oxidase genes in schizophrenia: further evidence for a role in schizophrenia.
    Shinkai T; De Luca V; Hwang R; Müller DJ; Lanktree M; Zai G; Shaikh S; Wong G; Sicard T; Potapova N; Trakalo J; King N; Matsumoto C; Hori H; Wong AH; Ohmori O; Macciardi F; Nakamura J; Kennedy JL
    Neuromolecular Med; 2007; 9(2):169-77. PubMed ID: 17627036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a nonsynonymous variant of DAOA with visuospatial ability in a bipolar family sample.
    Soronen P; Silander K; Antila M; Palo OM; Tuulio-Henriksson A; Kieseppä T; Ellonen P; Wedenoja J; Turunen JA; Pietiläinen OP; Hennah W; Lönnqvist J; Peltonen L; Partonen T; Paunio T
    Biol Psychiatry; 2008 Sep; 64(5):438-42. PubMed ID: 18466879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural, phylogenetic and docking studies of D-amino acid oxidase activator (DAOA), a candidate schizophrenia gene.
    Sehgal SA; Khattak NA; Mir A
    Theor Biol Med Model; 2013 Jan; 10():3. PubMed ID: 23286827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional cortical thinning in subjects with high genetic loading for schizophrenia.
    Byun MS; Kim JS; Jung WH; Jang JH; Choi JS; Kim SN; Choi CH; Chung CK; An SK; Kwon JS
    Schizophr Res; 2012 Nov; 141(2-3):197-203. PubMed ID: 22998933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between DAOA gene polymorphisms and the risk of schizophrenia, bipolar disorder and depressive disorder.
    Tan J; Lin Y; Su L; Yan Y; Chen Q; Jiang H; Wei Q; Gu L
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():89-98. PubMed ID: 24447945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.